Adaptive Biotechnologies, Seattle, WA

Adaptive Biotechnologies

www.adaptivebiotech.com

Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people`s lives by learning from the wisdom of their adaptive immune systems. Adaptive`s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated.

Number of Employees: 250-1000
Annual Revenue: $50-100 Million

www.adaptivebiotech.com
1551 Eastlake Avenue East Suite 200
Seattle, WA USA 98102
Phone: 206.659.0067

Name	Title	Contact Details
David Arbo	Sr Director of Information Technology	Profile
Josh Schmidt	Senior Director, Information Security	Profile
Mark Adams	Chief Technical Officer	Profile
Mark Adams	Chief Operating Officer	Profile

Similar Companies

Dechra

Dechra Pharmaceuticals PLC is a global leader in veterinary pharmaceuticals, dedicated exclusively to the veterinary market. Founded in 1997, the company has a rich history dating back to 1819. Dechra develops, manufactures, and markets high-quality pharmaceutical products and services aimed at improving animal health and welfare. It operates in 24 countries and distributes products in over 50 countries. The company offers a diverse portfolio of prescription-only veterinary medicines for companion animals and horses, focusing on areas such as endocrinology, dermatology, and critical care. Dechra also provides water-soluble antibiotics, poultry vaccines, and specialized diets. Its services division includes laboratories that support veterinary diagnostics. With a strong emphasis on understanding veterinarians needs, Dechra provides training and scientific resources to enhance animal care.

CTOs on the Move